Logo image of USNA

USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis

NYSE:USNA - New York Stock Exchange, Inc. - US90328M1071 - Common Stock - Currency: USD

31.78  -0.31 (-0.97%)

After market: 31.78 0 (0%)

Fundamental Rating

6

Overall USNA gets a fundamental rating of 6 out of 10. We evaluated USNA against 37 industry peers in the Personal Care Products industry. USNA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. USNA has a bad growth rate and is valued cheaply. This makes USNA very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

USNA had positive earnings in the past year.
In the past year USNA had a positive cash flow from operations.
USNA had positive earnings in each of the past 5 years.
Each year in the past 5 years USNA had a positive operating cash flow.
USNA Yearly Net Income VS EBIT VS OCF VS FCFUSNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

1.2 Ratios

USNA has a Return On Assets of 8.09%. This is in the better half of the industry: USNA outperforms 77.78% of its industry peers.
USNA has a Return On Equity of 10.19%. This is in the better half of the industry: USNA outperforms 75.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.33%, USNA is in the better half of the industry, outperforming 69.44% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for USNA is above the industry average of 13.42%.
The 3 year average ROIC (17.38%) for USNA is well above the current ROIC(9.33%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 8.09%
ROE 10.19%
ROIC 9.33%
ROA(3y)13.96%
ROA(5y)16.16%
ROE(3y)19.43%
ROE(5y)23.02%
ROIC(3y)17.38%
ROIC(5y)19.97%
USNA Yearly ROA, ROE, ROICUSNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 6.30%, USNA is in the better half of the industry, outperforming 69.44% of the companies in the same industry.
USNA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.55%, USNA is in the better half of the industry, outperforming 63.89% of the companies in the same industry.
USNA's Operating Margin has declined in the last couple of years.
USNA's Gross Margin of 80.86% is amongst the best of the industry. USNA outperforms 100.00% of its industry peers.
USNA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.55%
PM (TTM) 6.3%
GM 80.86%
OM growth 3Y-13.39%
OM growth 5Y-8.6%
PM growth 3Y-14.27%
PM growth 5Y-8.18%
GM growth 3Y-0.31%
GM growth 5Y-0.56%
USNA Yearly Profit, Operating, Gross MarginsUSNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

9

2. Health

2.1 Basic Checks

USNA has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for USNA has been reduced compared to 1 year ago.
USNA has less shares outstanding than it did 5 years ago.
The debt/assets ratio for USNA is higher compared to a year ago.
USNA Yearly Shares OutstandingUSNA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
USNA Yearly Total Debt VS Total AssetsUSNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

USNA has an Altman-Z score of 5.93. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 5.93, USNA is doing good in the industry, outperforming 77.78% of the companies in the same industry.
There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.93
ROIC/WACC1.03
WACC9.06%
USNA Yearly LT Debt VS Equity VS FCFUSNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 3.93 indicates that USNA has no problem at all paying its short term obligations.
USNA has a Current ratio of 3.93. This is amongst the best in the industry. USNA outperforms 88.89% of its industry peers.
A Quick Ratio of 3.37 indicates that USNA has no problem at all paying its short term obligations.
USNA has a Quick ratio of 3.37. This is amongst the best in the industry. USNA outperforms 86.11% of its industry peers.
Industry RankSector Rank
Current Ratio 3.93
Quick Ratio 3.37
USNA Yearly Current Assets VS Current LiabilitesUSNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2

3. Growth

3.1 Past

USNA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.41%.
Measured over the past years, USNA shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.37% on average per year.
USNA shows a decrease in Revenue. In the last year, the revenue decreased by -7.11%.
The Revenue has been decreasing by -4.98% on average over the past years.
EPS 1Y (TTM)-8.41%
EPS 3Y-17.42%
EPS 5Y-8.37%
EPS Q2Q%-5.08%
Revenue 1Y (TTM)-7.11%
Revenue growth 3Y-6.72%
Revenue growth 5Y-4.98%
Sales Q2Q%-6.16%

3.2 Future

Based on estimates for the next years, USNA will show a decrease in Earnings Per Share. The EPS will decrease by -0.83% on average per year.
The Revenue is expected to grow by 3.88% on average over the next years.
EPS Next Y-24.27%
EPS Next 2Y-6.47%
EPS Next 3Y-0.83%
EPS Next 5YN/A
Revenue Next Year-6.86%
Revenue Next 2Y2.01%
Revenue Next 3Y3.88%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USNA Yearly Revenue VS EstimatesUSNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
USNA Yearly EPS VS EstimatesUSNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.23, the valuation of USNA can be described as reasonable.
83.33% of the companies in the same industry are more expensive than USNA, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of USNA to the average of the S&P500 Index (29.63), we can say USNA is valued rather cheaply.
A Price/Forward Earnings ratio of 11.01 indicates a reasonable valuation of USNA.
Based on the Price/Forward Earnings ratio, USNA is valued cheaper than 88.89% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. USNA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.23
Fwd PE 11.01
USNA Price Earnings VS Forward Price EarningsUSNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 97.22% of the companies listed in the same industry.
USNA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. USNA is cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.22
EV/EBITDA 2.58
USNA Per share dataUSNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of USNA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.47%
EPS Next 3Y-0.83%

0

5. Dividend

5.1 Amount

No dividends for USNA!.
Industry RankSector Rank
Dividend Yield N/A

USANA HEALTH SCIENCES INC

NYSE:USNA (2/21/2025, 8:04:00 PM)

After market: 31.78 0 (0%)

31.78

-0.31 (-0.97%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)10-22 2024-10-22/amc
Earnings (Next)02-25 2025-02-25/amc
Inst Owners58.43%
Inst Owner Change1.11%
Ins Owners0.74%
Ins Owner Change0.43%
Market Cap605.73M
Analysts43.33
Price Target52.53 (65.29%)
Short Float %5.24%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.74%
Min EPS beat(2)-18.68%
Max EPS beat(2)13.2%
EPS beat(4)3
Avg EPS beat(4)20.59%
Min EPS beat(4)-18.68%
Max EPS beat(4)65.46%
EPS beat(8)6
Avg EPS beat(8)25.45%
EPS beat(12)6
Avg EPS beat(12)12.81%
EPS beat(16)9
Avg EPS beat(16)11.72%
Revenue beat(2)0
Avg Revenue beat(2)-5.09%
Min Revenue beat(2)-5.56%
Max Revenue beat(2)-4.61%
Revenue beat(4)1
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)2.05%
Revenue beat(8)4
Avg Revenue beat(8)-0.33%
Revenue beat(12)5
Avg Revenue beat(12)-1.33%
Revenue beat(16)8
Avg Revenue beat(16)-0.73%
PT rev (1m)10.75%
PT rev (3m)7.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.23
Fwd PE 11.01
P/S 0.7
P/FCF 9.22
P/OCF 7.46
P/B 1.14
P/tB 1.24
EV/EBITDA 2.58
EPS(TTM)2.83
EY8.9%
EPS(NY)2.89
Fwd EY9.08%
FCF(TTM)3.45
FCFY10.84%
OCF(TTM)4.26
OCFY13.41%
SpS45.22
BVpS27.97
TBVpS25.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.09%
ROE 10.19%
ROCE 14.79%
ROIC 9.33%
ROICexc 27.08%
ROICexgc 35.74%
OM 9.55%
PM (TTM) 6.3%
GM 80.86%
FCFM 7.62%
ROA(3y)13.96%
ROA(5y)16.16%
ROE(3y)19.43%
ROE(5y)23.02%
ROIC(3y)17.38%
ROIC(5y)19.97%
ROICexc(3y)44.61%
ROICexc(5y)53.22%
ROICexgc(3y)61.8%
ROICexgc(5y)75.33%
ROCE(3y)27.57%
ROCE(5y)31.69%
ROICexcg growth 3Y-24.2%
ROICexcg growth 5Y-22.07%
ROICexc growth 3Y-22.67%
ROICexc growth 5Y-19.19%
OM growth 3Y-13.39%
OM growth 5Y-8.6%
PM growth 3Y-14.27%
PM growth 5Y-8.18%
GM growth 3Y-0.31%
GM growth 5Y-0.56%
F-Score7
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 115.79%
Cap/Sales 1.81%
Interest Coverage 583.92
Cash Conversion 84.83%
Profit Quality 120.87%
Current Ratio 3.93
Quick Ratio 3.37
Altman-Z 5.93
F-Score7
WACC9.06%
ROIC/WACC1.03
Cap/Depr(3y)112.9%
Cap/Depr(5y)112.37%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.45%
Profit Quality(3y)102.14%
Profit Quality(5y)106.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.41%
EPS 3Y-17.42%
EPS 5Y-8.37%
EPS Q2Q%-5.08%
EPS Next Y-24.27%
EPS Next 2Y-6.47%
EPS Next 3Y-0.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.11%
Revenue growth 3Y-6.72%
Revenue growth 5Y-4.98%
Sales Q2Q%-6.16%
Revenue Next Year-6.86%
Revenue Next 2Y2.01%
Revenue Next 3Y3.88%
Revenue Next 5YN/A
EBIT growth 1Y-9.92%
EBIT growth 3Y-19.21%
EBIT growth 5Y-13.15%
EBIT Next Year18.7%
EBIT Next 3Y8.12%
EBIT Next 5YN/A
FCF growth 1Y-8.14%
FCF growth 3Y-27.16%
FCF growth 5Y-16.78%
OCF growth 1Y-7.99%
OCF growth 3Y-23.92%
OCF growth 5Y-14.22%